Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North
P.O. Box 19024
Seattle
Washington
98109-1024
United States
Tel: (206) 667-4700
Website: http://www.fredhutch.org/
178 articles with Fred Hutchinson Cancer Research Center
-
Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230
10/21/2019
Planned Phase 2 Multi-Site Trial to Evaluate ALKS 4230 in Combination With Pembrolizumab in Patients With Advanced or Recurrent Head and Neck Squamous Cell Cancer
-
ElevateBio Launches HighPassBio to Advance Novel Targeted T Cell Immunotherapies with Technology from Fred Hutchinson Cancer Research Center
10/1/2019
T cell receptor (TCR) T cell therapy targeting HA-1 expressing tumors designed to manage post-hematopoietic stem cell transplant leukemic relapse
-
Hyundai Hope On Wheels Presents Fred Hutchinson Cancer Research Center With $300,000 Hyundai Scholar Hope Grant To Support Pediatric Cancer Research
9/24/2019
The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [24-September-2019] SEATTLE , Sept. 24, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyun
-
Fred Hutchinson Cancer Research Center and Leica Microsystems Establish Center of Excellence in Microscopy
9/3/2019
Fred Hutchinson Cancer Research Center and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at Fred Hutch.
-
EpiCypher® announces the launch of CUTANA™ (ChIC / CUT&RUN / CUT&Tag) for next-generation genomic mapping studies
7/23/2019
EpiCypher, Inc. announces the commercial licensing of ChIC (University of Geneva) and CUT&RUN / CUT&Tag (Fred Hutchinson Cancer Research Center) technologies.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.
-
January 25 Research Roundup: Alzheimer’s Memory Recovery and Testing, New Antibiotics, Possible S...
1/25/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities
10/22/2018
The U.S. Bureau of Labor Statistics predicts a 7 percent increase in jobs for biomedical engineers and a 13 percent increase in medical scientists. -
GO Therapeutics, headquartered in Cambridge, Mass., signed a licensing deal with Swiss-based Roche to develop antibodies for cancer.
-
Some cancer cells have a remarkable and frightening sense of self-preservation to avoid immunotherapy treatments. That is the finding from a new study conducted by researchers at the Fred Hutchinson Cancer Research Center in Seattle.
-
By many standards, and certainly by the way the media covers it and industry promotes it, immuno-oncology therapies using CAR-T are revolutionizing cancer treatments. But what if, as the saying goes, they threw a revolution and nobody came? Or more precisely, what if they threw a revolution and n...
-
Evotec Forms Academic Bridge 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center
5/31/2018
Initial term of LAB591 is five years.
-
ACEA Biosciences Hosted Cancer and Immunotherapy Symposium for Leading Scientists in T Cell Therapy
5/3/2018
ACEA Biosciences, a biotechnology company that develops high performance cell analysis instruments, hosted their 6th annual Cancer Immunotherapy Symposium focused on CAR-T cell and TCR therapy on April 14, 2018 at the W Hotel in Chicago, prior to the 2018 AACR Annual Meeting.
-
Trianni Signs Collaboration Agreement With Fred Hutchinson Cancer Research Center For Use Of The Trianni Mouse Platform
3/8/2017
-
10X Genomics Release: Company Announces Publication Of Study In Nature Communications Demonstrating Single Cell Profiling In Leukemia Patients By The Fred Hutchinson Cancer Research Center
1/16/2017
-
Fred Hutchinson Cancer Research Center Team Wants To Move Clean-Room Gene Therapy To Tabletop
10/27/2016
-
Study Conducted At Fred Hutchinson Cancer Research Center Shows Transplant Patients Benefit From Glytec LLC's System For Computer-Guided Glucose Management
10/12/2016
-
Fred Hutchinson Cancer Research Center Appoints FY 2016-17 Board Members, Including Microsoft CEO Satya Nadella
7/11/2016
-
Juno and Blaze Bioscience's Success Inspires Fred Hutchinson Cancer Research Center to Spin Out More Companies Faster
6/7/2016